Aktis Oncology Inc AKY-2519 Clinical Imaging and Dosimetry Data Conference Call Transcript
Good day and thank you for standing by. Welcome to the Access Oncology conference call. (Operator Instructions) Please be advised that today's conference is being.
I would now like to hand the conference over to your speaker today, Alex Loeb, Investor Relations. Please go ahead, sir.
Thank you, Michelle. Before we begin, I'd like to remind you that today's remarks will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1,995.
We ask that you refer to our filings on sec.gov, including our most recent annual report on Form 10-K filed with the SEC on March 30, 2026, for a full list of risks. And uncertainties.
Actual results may differ materially from those indicated by these statements.
Unless required by securities law, Actus does not undertake any obligation to update these statements regarding the future or to confirm these statements in relation to actual events.
With that, I'd like to turn your call over to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
